Ameriprise
BIO icon

Ameriprise’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ameriprise’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.02M Sell
18,023
-188
-1% -$54.1K ﹤0.01% 2430
2025
Q4 		$5.52M Sell
18,211
-1,778
-9% -$555K ﹤0.01% 2361
2025
Q3 		$5.6M Sell
19,989
-7,412
-27% -$2.02M ﹤0.01% 2356
2025
Q2 		$6.61M Sell
27,401
-4,387
-14% -$1.04M ﹤0.01% 2137
2025
Q1 		$7.74M Sell
31,788
-2,394
-7% -$720K ﹤0.01% 1958
2024
Q4 		$11.2M Buy
34,182
+571
+2% +$194K ﹤0.01% 1708
2024
Q3 		$11.2M Buy
33,611
+16,910
+101% +$5.37M ﹤0.01% 1687
2024
Q2 		$4.56M Buy
16,701
+4,868
+41% +$1.42M ﹤0.01% 2379
2024
Q1 		$4.09M Buy
11,833
+43
+0.4% +$14.1K ﹤0.01% 2484
2023
Q4 		$3.81M Sell
11,790
-408
-3% -$128K ﹤0.01% 2538
2023
Q3 		$4.37M Sell
12,198
-98
-0.8% -$37.8K ﹤0.01% 2381
2023
Q2 		$4.66M Sell
12,296
-2,298
-16% -$935K ﹤0.01% 2397
2023
Q1 		$6.99M Buy
14,594
+2,228
+18% +$1.04M ﹤0.01% 2069
2022
Q4 		$5.24M Buy
12,366
+868
+8% +$350K ﹤0.01% 2259
2022
Q3 		$4.8M Sell
11,498
-594
-5% -$296K ﹤0.01% 2261
2022
Q2 		$5.98M Sell
12,092
-8,839
-42% -$4.6M ﹤0.01% 2140
2022
Q1 		$11.8M Sell
20,931
-47,935
-70% -$28.9M ﹤0.01% 1783
2021
Q4 		$52M Buy
68,866
+679
+1% +$508K 0.01% 823
2021
Q3 		$51M Sell
68,187
-32,055
-32% -$24M 0.02% 768
2021
Q2 		$64.6M Buy
100,242
+8,761
+10% +$5.33M 0.02% 680
2021
Q1 		$52.2M Sell
91,481
-74,716
-45% -$44.2M 0.02% 753
2020
Q4 		$96.9M Sell
166,197
-2,218
-1% -$1.26M 0.03% 485
2020
Q3 		$86.8M Sell
168,415
-17,496
-9% -$8.86M 0.04% 466
2020
Q2 		$83.9M Sell
185,911
-31,097
-14% -$13.7M 0.04% 439
2020
Q1 		$76.1M Buy
217,008
+151,358
+231% +$55.7M 0.04% 416
2019
Q4 		$24.2M Buy
65,650
+6,286
+11% +$2.22M 0.01% 1045
2019
Q3 		$19.8M Buy
59,364
+567
+1% +$185K 0.01% 1152
2019
Q2 		$18.4M Sell
58,797
-1,650
-3% -$494K 0.01% 1232
2019
Q1 		$18.5M Sell
60,447
-1,189
-2% -$321K 0.01% 1201
2018
Q4 		$14.3M Sell
61,636
-3,842
-6% -$1.03M 0.01% 1302
2018
Q3 		$20.5M Sell
65,478
-1,463
-2% -$454K 0.01% 1274
2018
Q2 		$19.3M Buy
66,941
+767
+1% +$212K 0.01% 1204
2018
Q1 		$16.5M Buy
66,174
+431
+0.7% +$110K 0.01% 1263
2017
Q4 		$15.7M Buy
65,743
+3,713
+6% +$900K 0.01% 1253
2017
Q3 		$13.8M Sell
62,030
-7,414
-11% -$1.67M 0.01% 1328
2017
Q2 		$15.7M Buy
69,444
+450
+0.7% +$98.1K 0.01% 1201
2017
Q1 		$13.8M Sell
68,994
-2,447
-3% -$471K 0.01% 1284
2016
Q4 		$13M Buy
71,441
+7,320
+11% +$1.25M 0.01% 1308
2016
Q3 		$10.5M Buy
64,121
+8,820
+16% +$1.34M 0.01% 1403
2016
Q2 		$7.91M Buy
55,301
+1,627
+3% +$232K ﹤0.01% 1588
2016
Q1 		$7.34M Sell
53,674
-62,718
-54% -$8.23M ﹤0.01% 1678
2015
Q4 		$16.1M Sell
116,392
-8,483
-7% -$1.18M 0.01% 1076
2015
Q3 		$16.8M Sell
124,875
-28,485
-19% -$4.1M 0.01% 1060
2015
Q2 		$23.1M Sell
153,360
-10,144
-6% -$1.45M 0.01% 909
2015
Q1 		$22.1M Buy
163,504
+6,277
+4% +$778K 0.01% 940
2014
Q4 		$19M Buy
157,227
+16,310
+12% +$1.88M 0.01% 1002
2014
Q3 		$16M Buy
140,917
+4,937
+4% +$585K 0.01% 1103
2014
Q2 		$16.3M Sell
135,980
-714
-0.5% -$87.2K 0.01% 1180
2014
Q1 		$17.5M Buy
136,694
+75,149
+122% +$9.63M 0.01% 1094
2013
Q4 		$7.61M Buy
61,545
+377
+0.6% +$45.9K ﹤0.01% 1698
2013
Q3 		$7.19M Buy
61,168
+2,936
+5% +$346K ﹤0.01% 1689
2013
Q2 		$6.53M Buy
+58,232
New +$6.83M ﹤0.01% 1721

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise's BIO Position: Q1 2026 in Review

Ameriprise reduced its Bio-Rad Laboratories Class A (BIO) stake by 1% in Q1 2026, selling an estimated $54.1K and leaving 18,023 shares worth $5.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

Ameriprise first reported a position in BIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $96.9M in Q4 2020. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Ameriprise held 18,023 shares of Bio-Rad Laboratories Class A worth $5.02M as of Q1 2026.
  • Ameriprise sold 188 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $54.1K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2430 holding.
  • Ameriprise first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Bio-Rad Laboratories Class A position peaked at $96.9M in Q4 2020.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.